Skip to content

Examination of utility of PPI on-demand treatment to the epigastrium symptom and the best dosage

Examination of utility of PPI on-demand treatment to the epigastrium symptom and the best dosage - Examination of utility of PPI on-demand treatment to the epigastrium symptom and the best dosage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000002621
Enrollment
240
Registered
2009-11-01
Start date
2009-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The epigastrium symptom

Interventions

&quot
therapy of omepral 20mg for 4 weeks continuous therapy of omepral 20mg for 4 weeks continuous therapy of omepral 10mg for 4 weeks

Sponsors

Kawasaki Medical School attachment Kawasaki hospital Gastroenterology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)The patient of the endoscopy unexecution within three months in the past. there are a repetition of the relapse ..chronic.. and an abdomen symptom 2)It is a symptom questionnaire survey and the GOS score is a patient of four or more. 3)H. pylori is a gloomy patient in urine according to the antibody method.

Exclusion criteria

Exclusion criteria: 1) Pregnant women and patienst while suckling, and patients who have been hoping for pregnancy for the trial period. 2) Patients who had the past of irritability for omeprazole 3) Patients who suffer from serious liver disease, kidney disease, heart disease, or Haematological disorder 4) Patients who are judged inappropriate for the clinical trial by doctors.

Design outcomes

Primary

MeasureTime frame
Amount of change of GOS score between before and after treatment

Secondary

MeasureTime frame
Examination according to symptoms Evaluation of safety

Countries

Japan

Contacts

Public ContactYoshinori Fujimura

Kawasaki Medical School Kawasaki hospital Gastroenterology

066-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026